Saudi Arabia is the largest of the Arabian Gulf countries with a total population of 33.41 million as of 2017. This report summarizes the experience from four leading tertiary care hematopoietic stem cell transplantation (HSCT) centers in Saudi Arabia representing more than 90% of all HSCTs performed in the country. Between 1984 and 2016, a total of 6,184 HSCTs were performed. Of these, 3,586 HSCTs were performed in adults and 2,598 HSCTs were performed in pediatric patients. Malignancy was the main indication for transplantation (47%). While most transplants were performed from an identical sibling donor, HSCTs from cord blood, unrelated and, more recently, haploidentical donors have also been performed. Relative shortage of HSCT bed capacity is perceived to be a limiting factor in Saudi Arabia. Lately, more HSCT centers are emerging with rapid growth, which may significantly improve the access to HSCT in the country in the near future.
Cite this Article (APA)
Marwan, S., Fahad, A., Naif, A., Mouhab, A., Naeem, C., Ibraheem, A., Sultan, A., Mohammed, A., Fahad, A., Saad, A., Hind, A., Walid, R., Feras, A., Khalid, A., Hani, A., Saad, A., Amr, H., Khalid, A., Hazzaa, A., Khalid, I., Moheeb, A., Bassim, A., Amal, A., Amal, A., Ibraheem, M., Syed, Z. Z., Syed, O. A., Abdullah, A., Fazal, H., Ali, A., Shahrukh, H. (2021). Hematopoietic stem cell transplantation in Saudi Arabia between 1984 and 2016. Hematology/Oncology and Stem Cell Therapy. https://doi.org/10.1016/j.hemonc.2020.07.008
